These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3488964)

  • 1. Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis.
    Alderete JF; Kasmala L
    Infect Immun; 1986 Sep; 53(3):697-9. PubMed ID: 3488964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to a major surface glycoprotein immunogen differentiates isolates and subpopulations of Trichomonas vaginalis.
    Alderete JF; Suprun-Brown L; Kasmala L
    Infect Immun; 1986 Apr; 52(1):70-5. PubMed ID: 3514466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.
    Moav N; Draghi E; David A; Gold D
    Immunology; 1988 Jan; 63(1):63-9. PubMed ID: 2448233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis.
    Alderete JF; Demĕs P; Gombosová A; Valent M; Yánoska A; Fabusová H; Kasmala L; Garza GE; Metcalfe EC
    Infect Immun; 1987 May; 55(5):1037-41. PubMed ID: 2437029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.
    Alderete JF; Newton E; Dennis C; Engbring J; Neale KA
    Genitourin Med; 1991 Jun; 67(3):220-5. PubMed ID: 2071124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus.
    Shaio MF; Lin PR; Lee CS
    Int J Parasitol; 1993 Aug; 23(5):675-80. PubMed ID: 8225773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomonas vaginalis NYH286 phenotypic variation may be coordinated for a repertoire of trichomonad surface immunogens.
    Alderete JF
    Infect Immun; 1987 Sep; 55(9):1957-62. PubMed ID: 3497876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants.
    Alderete JF; Kasmala L; Metcalfe E; Garza GE
    Infect Immun; 1986 Aug; 53(2):285-93. PubMed ID: 2426199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against Trichomonas vaginalis.
    Chang TH; Tsing SY; Tzeng S
    Hybridoma; 1986; 5(1):43-51. PubMed ID: 3514432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequestration of host-CD59 as potential immune evasion strategy of Trichomonas vaginalis.
    Ibáñez-Escribano A; Nogal-Ruiz JJ; Pérez-Serrano J; Gómez-Barrio A; Escario JA; Alderete JF
    Acta Trop; 2015 Sep; 149():1-7. PubMed ID: 25976413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and identification of anti-Trichomonas vaginalis monoclonal antibodies].
    Gao XZ; Mao YD; Tang ZH; Yu C; Zhu YH; Yang FY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(2):139-42. PubMed ID: 1394911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immunoglobulin and complement in enhancing the respiratory burst of neutrophils against Trichomonas vaginalis.
    Shaio MF; Chang FY; Hou SC; Lee CS; Lin PR
    Parasite Immunol; 1991 May; 13(3):241-50. PubMed ID: 1852474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases.
    Alderete JF; Newton E; Dennis C; Neale KA
    Genitourin Med; 1991 Dec; 67(6):469-74. PubMed ID: 1774051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus.
    Demes P; Gombosová A; Valent M; Jánoska A; Fabusová H; Petrenko M
    Genitourin Med; 1988 Jun; 64(3):176-9. PubMed ID: 3261708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.
    Alderete JF; Suprun-Brown L; Kasmala L; Smith J; Spence M
    Infect Immun; 1985 Sep; 49(3):463-8. PubMed ID: 2411656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron mediates Trichomonas vaginalis resistance to complement lysis.
    Alderete JF; Provenzano D; Lehker MW
    Microb Pathog; 1995 Aug; 19(2):93-103. PubMed ID: 8577239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells.
    Arroyo R; Alderete JF
    Infect Immun; 1989 Oct; 57(10):2991-7. PubMed ID: 2789190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunogenic and antibody-binding membrane proteins of pathogenic Trichomonas vaginalis.
    Alderete JF
    Infect Immun; 1983 Apr; 40(1):284-91. PubMed ID: 6339404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic heterogeneity in the 115,000 Mr major surface antigen of Trichomonas vaginalis.
    Torian BE; Connelly RJ; Barnes RC; Kenny GE
    J Protozool; 1988 May; 35(2):273-80. PubMed ID: 2456385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.